We used a panel of ten different antibodies, including CD20, CD24, CD34, CD45, CD73, CD90, CD105, E-cadherin, fibronectin, and laminin, to identify different viable cell types in breast cancer PDOs, Supplementary Table S1. Here, FN1 is linked to breast carcinoma.